| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Product containing precisely budesonide 3 milligram/1 each conventional release oral capsule (clinical drug) |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Bromazepam 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Auranofin 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Hydromorphone hydrochloride 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Auranofin 3 mg oral capsule |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Warfarin sodium 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Risperidone 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Rivastigmine (as rivastigmine tartrate) 3 mg oral capsule |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Oxybutynin hydrochloride 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ivermectin 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ropinirole hydrochloride 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| fluoxetinhydroklorid 25 milligram och olanzapin 3 milligram, oral kapsel |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely pomalidomide 3 milligram/1 each conventional release oral capsule (clinical drug) |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| flupentixol 3 mg, tablett |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Glimepiride 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Glibenclamide micronised 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Estropipate 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
2 |
| etinylestradiol 30 mikrogram + drospirenon 3 mg, tablett |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
2 |
| Eszopiclone 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Doxepin 3 mg oral tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Dinoprostone 3 mg vaginal tablet |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely apomorphine hydrochloride 3 milligram/1 each conventional release sublingual tablet (clinical drug) |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely budesonide 3 milligram/1 each gastro-resistant oral capsule (clinical drug) |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely prochlorperazine maleate 3 milligram/1 each conventional release buccal tablet (clinical drug) |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely ascorbic acid 10 milligram and ferrous gluconate 250 milligram and folic acid 5 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Caffeine 15 mg and codeine phosphate 15 mg and paracetamol 300 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely dichloralphenazone 100 milligram and isometheptene 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely amiloride hydrochloride 2.5 milligram and atenolol 50 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Carbidopa 12.5 mg and entacapone 200 mg and levodopa 50 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely clemastine fumarate 335 microgram and paracetamol 500 milligram and phenylpropanolamine 30 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| abakavir 300 milligram, lamivudin 150 milligram och zidovudin 300 milligram, oral tablett |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Dehydrocholic acid 180 mg and pancreatin 300 mg and simeticone 40 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Ascorbic acid 60 mg and cyanocobalamin 5 mg and ferrous fumarate 200 mg oral capsule |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Aspirin 325 mg and butalbital 50 mg and caffeine 40 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Caffeine 15 mg and codeine phosphate 30 mg and paracetamol 300 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Aspirin 770 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Aspirin 325 mg and carisoprodol 200 mg and codeine phosphate 16 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely isoniazid 50 milligram and pyrazinamide 300 milligram and rifampicin 120 milligram/1 each conventional release oral tablet (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Lamivudine 150 mg and nevirapine 200 mg and zidovudine 300 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely methyltestosterone 5 milligram and pemoline 10 milligram and yohimbine 5 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely oxytetracycline hydrochloride 250 milligram and phenazopyridine hydrochloride 50 milligram and sulfamethizole 250 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Phenazopyridine hydrochloride 200 mg and sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil fumarate 300 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Paracetamol 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Hydralazine hydrochloride 25 mg and hydrochlorothiazide 15 mg and reserpine 100 microgram oral tablet |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| ceftazidim (som ceftazidimpentahydrat) 3 gram/injektionsflaska, pulver till injektionsvätska |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cetrorelix (as cetrorelix acetate) 3 mg powder for solution for injection vial |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely triptorelin (as triptorelin acetate) 3 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely potassium aminobenzoate 3 gram/1 sachet powder for conventional release oral solution (clinical drug) |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely codeine phosphate 3 milligram/1 milliliter conventional release oral solution (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Prednisolone 3 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely phenobarbital 3 milligram/1 milliliter conventional release oral elixir (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely prednisolone 3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ephedrine hydrochloride 3 mg/mL oral solution |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| gentamicin (som gentamicinsulfat) 3 milligram/milliliter, öron- eller ögondroppar, lösning |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| hydroxipropylmetylcellulosa 0,32 %, ögondroppar |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Hypromellose 3 mg/mL eye drops |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely calamine 15 milligram/1 gram and dimeticone 200 milligram/1 gram and zinc oxide 75 milligram/1 gram conventional release cutaneous cream (clinical drug) |
räkning av bas i aktiv ingrediens |
False |
3 (qualifier value) |
Inferred relationship |
Some |
|
| Diflucortolone valerate 3 mg/g cutaneous ointment |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely calcitriol 3 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Heparinoid 3 mg/g cutaneous cream |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely heparinoid 3 milligram/1 gram conventional release cutaneous gel (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 milliliter and hydrocortisone acetate 10 milligram/1 milliliter conventional release ear drops (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
2 |
| Diflucortolone valerate 3 mg/g cutaneous cream |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely ofloxacin 3 milligram/1 milliliter conventional release eye drops (clinical drug) |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Ciprofloxacin (as ciprofloxacin hydrochloride) 3 mg/mL eye drops |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Dexamethasone 1 mg/mL and tobramycin 3 mg/mL eye drops |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| pamidronatdinatrium 60 mg/20 ml, injektionsvätska, lösning, flaska |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| pamidronatdinatrium 90 mg/30 ml, injektionsvätska, lösning, flaska |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| efedrinhydroklorid 30 mg/10 ml, injektionsvätska, lösning, ampull |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
har täljarvärde som visar styrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| Cetrimide 3 mg/g and dimeticone 1000 100 mg/g cutaneous cream |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
2 |
| adenosin 30 mg/10 ml, infusionsvätska, lösning, flaska |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |
| adenosin 6 mg/2 ml, injektionsvätska, lösning, flaska |
har täljarvärde för koncentrationsstyrka |
False |
3 (qualifier value) |
Inferred relationship |
Some |
1 |